American Well Corp

American Well Corp

AMWL · NYSE · Healthcare / Health Information Services

11.74USD-0.29 (-2.41%)

Price History

Full chart

Market Stats

Previous Close12.03
Open12.19
Day Range11.68 – 12.19
52-Week Range3.71 – 14.19
Volume52.30K
Market Cap225.06M
P/E (TTM)0.00
Forward P/E0.00
EPS-4.78
Dividend Yield0.00%
Beta1.71
50-Day Avg12.36
200-Day Avg7.84

About

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEODr. Ido Schoenberg M.D.
  • Employees562
  • Headquarters75 State Street, Boston, MA, United States, 02109, USA
  • Websitehttps://business.amwell.com

Leadership

  • Dr. Ido Schoenberg M.D.Chairman & CEO · b. 1965
  • Mr. Mark J. Hirschhorn CPAExecutive VP, COO & CFO · b. 1965
  • Mr. Dan ZamanskyChief Product & Technology Officer · b. 1984
  • Mr. Paul Francis McNeiceVice President of Accounting · b. 1977
  • Anna NesterovaHead of Legal & Deputy General Counsel
  • Mr. Michael MillerSenior Vice President & Chief Sales Officer
  • Ms. Phyllis I. GotlibPresident of Amwell International · b. 1958
  • Dr. Cynthia Horner FAAFP, M.D.Chief Medical Officer & President of Amwell Medical Group

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue113.95M148.86M245.26M252.79M277.19M259.05M254.36M249.32M
Growth (%)-+30.63%+64.77%+3.07%+9.65%-6.55%-1.81%-1.98%
Cost of Revenue58.61M79.98M156.79M148.47M160.42M164.29M155.41M116.47M
Gross Profit55.34M68.88M88.47M104.31M116.77M94.76M98.95M132.86M
Gross Margin48.57%46.27%36.07%41.27%42.13%36.58%38.90%53.29%
Operating Expense110.45M163.59M315.91M283.46M392.62M786.90M316.49M238.13M
Operating Income-55.11M-94.70M-227.43M-179.15M-275.85M-692.14M-217.53M-105.27M
Operating Margin-48.36%-63.62%-92.73%-70.87%-99.52%-267.19%-85.52%-42.22%
EBITDA-49.78M-86.94M-217.28M-166.07M-245.84M-224.15M-176.91M-60.57M
EBITDA Margin-43.68%-58.41%-88.59%-65.69%-88.69%-86.53%-69.55%-24.29%
Net Income-52.67M-87.19M-224.43M-176.33M-270.43M-675.16M-208.14M-95.70M
Net Income Margin-46.22%-58.57%-91.51%-69.76%-97.56%-260.63%-81.83%-38.38%
R&D36.27M53.94M84.41M106.59M138.49M105.83M86.06M72.86M
R&D as % of Total Revenue31.83%36.24%34.42%42.17%49.96%40.85%33.84%29.22%
Interest Expense06.71M1.63M120.00K6.12M19.42M-3.80M
Interest Expense % of Total Revenue0.00%4.51%0.67%0.05%2.21%7.50%-1.53%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets489.31M499.88M1.38B1.45B1.22B589.71M435.97M323.79M
Total Liabilities693.72M124.95M130.45M184.96M133.71M109.52M119.72M76.00M
Total Equity343.87M348.68M1.22B1.24B1.06B464.22M304.77M235.58M
Cash47.98M137.67M941.62M746.42M538.55M372.04M228.32M182.33M
Total Debt-13.40M7.65M16.61M14.84M11.79M8.20M4.52M
Net Debt-47.98M-124.28M-933.96M-729.80M-523.70M-360.25M-220.12M-177.80M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-74.01M-81.89M-112.46M-141.54M-192.32M-148.34M-127.34M-65.95M
Investing Cash Flow-245.93M120.00M-66.76M-59.63M-11.63M-19.17M-18.65M17.10M
Financing Cash Flow278.18M46.64M983.12M5.75M-3.61M2.15M1.38M840.00K
Capital Expenditure1.91M1.34M3.32M559.00K10.45M15.25M15.22M21.00K
Free Cash Flow-75.92M-83.23M-115.78M-142.10M-202.77M-163.59M-142.56M-65.97M
FCF to OCF102.58%101.63%102.95%100.39%105.43%110.28%111.95%100.03%

Earnings

Report DateSep 18, 2020Nov 12, 2020Mar 24, 2021May 12, 2021Aug 11, 2021Nov 10, 2021Feb 24, 2022May 9, 2022Aug 4, 2022Nov 7, 2022Feb 22, 2023May 3, 2023Aug 2, 2023Nov 1, 2023Feb 14, 2024May 1, 2024Jul 31, 2024Oct 30, 2024Feb 12, 2025May 1, 2025Aug 5, 2025Nov 4, 2025Feb 12, 2026May 5, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate0.00-5.39-0.26-3.64-3.51-4.30-0.27-4.02-4.21-4.19-0.25-3.48-3.72-3.62-3.30-3.41-3.40-3.11-2.55-1.88-1.11-1.46-1.59-0.77-0.60-0.66
EPS Actual-0.11-5.25-0.51-3.06-2.92-3.46-0.18-3.97-4.66-3.36-0.22-3.68-3.19-2.74-2.51-0.17-2.68-2.29-1.96-1.17-0.72-1.55-1.12-0.67-0.59-
Surprise-2.60%-96.15%15.93%16.81%19.53%33.33%1.24%-10.69%19.81%12.00%-5.75%14.25%24.31%23.94%95.01%21.18%26.37%23.14%37.77%35.14%-6.16%29.56%12.99%1.67%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap225.06M
Enterprise Value31.72M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.05
Price / Book1.02
EPS-4.78
Book Value13.07
Revenue (TTM)218.52M
Gross Profit (TTM)114.91M
EBITDA-39.89M
Profit Margin-35.75%
Operating Margin-19.59%
Return on Equity-29.12%
Return on Assets-12.65%
Shares Outstanding15.06M
Shares Float11.93M
Beta1.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 9 analystsTarget 12.80
  • Strong Buy
    1
  • Hold
    8

Ownership Breakdown

Institutions
50.83%
Insiders
5.39%
Retail / Other
43.78%

Top Institutional Holders

  • Morgan Stanley - Brokerage Accounts
    1.16M6.80%
  • RIMA MANAGEMENT, LLC
    1.14M6.68%
  • Cable Car Capital LLC
    1.00M5.89%
  • Vanguard Capital Management, LLC
    567.27K3.34%
  • Acadian Asset Management LLC
    406.62K2.39%
  • BlackRock Inc
    391.38K2.30%
  • Renaissance Technologies Corp
    195.02K1.15%
  • Geode Capital Management, LLC
    188.37K1.11%
  • Two Sigma Investments LLC
    145.10K0.85%
  • Rock Point Advisors, LLC
    134.36K0.79%
  • The Goldman Sachs Group Inc
    123.60K0.73%
  • Dimensional Fund Advisors, Inc.
    122.50K0.72%
  • Vanguard Fiduciary Trust Co
    79.93K0.47%
  • State Street Corp
    56.60K0.33%
  • Jane Street Group LLC
    54.11K0.32%
  • Lotus Technology Management, LP
    50.00K0.29%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    427.29K2.51%
  • Russell Inv US Small Cap Equity Y
    69.55K0.41%
  • Fidelity Extended Market Index
    64.91K0.38%
  • BSF Systematic US Eq Abs Ret A2 USD
    58.13K0.34%

Stock Splits

  • Jul 11, 20241:20